Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • Scientists Finish the Human Genome at Last https://t.co/bTRwmNjHwP
    about 6 hours ago
  • While the public's attention for the past 18 months has been focused on Covid-19, the problem of opioid overdoses a… https://t.co/gr0q6FkShP
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Drug Overdose Epidemic Accelerating https://t.co/rZP0zmFVgK #Science #Business
    about 1 day ago
  • "Unvaccinated people aren’t a random group of defectors who are trying to be deviant." @edyong209 talks to Dr. Rhea… https://t.co/FkzZWK83OE
    about 1 day ago
  • U.S. drops cases against five researchers accused of hiding ties to Chinese military https://t.co/0D4YvwvjZq
    about 2 days ago

Please share Science & Enterprise

Sanofi Aventis to Close Pennsylvania R&D Center

The Pottstown Mercury reports today that pharmaceutical company Sanofi Aventis, based in France, will close its Great Valley, Pennsylvania research and development site by July 2011. The Mercury says Sanofi Aventis will keep clinical supply and related support activities at the Great Valley site.

Elizabeth Baxter, a spokesperson for Sanofi Aventis, told the Mercury that the company plans to offer 303 Great Valley employees positions in other research facilities in Bridgewater, New Jersey and Cambridge, Massachusetts. Some 45 workers will remain to handle the clinical supply work, but 105 of the current staff will be laid off.

Related: Sanofi-aventis, Scripps to Partner on Personalized Medicines

Hat tip: Fierce Biotech

Comments are closed.